MetaVia granted Nasdaq time to fix sub-$1.00 share price
Rhea-AI Filing Summary
MetaVia Inc. (MTVA) reports that Nasdaq has granted the company a 180‑day extension, until May 26, 2026, to regain compliance with Nasdaq’s minimum bid price requirement, which calls for a closing bid of at least $1.00 per share for 10 consecutive business days. The extension follows an earlier notice that MetaVia’s stock had traded below $1.00 for 30 straight trading days.
MetaVia noted it had more than $5 million in stockholders’ equity as of September 30, 2025 and already has shareholder approval to implement a reverse stock split at a ratio between 1‑for‑5 and 1‑for‑30 at the board’s discretion. The company plans to monitor its share price and may use a reverse split to help restore compliance. If it does not regain compliance by the new deadline, its shares could be subject to delisting from Nasdaq, though the company would be able to appeal.
Positive
- None.
Negative
- Ongoing Nasdaq compliance risk: MetaVia remains out of compliance with Nasdaq’s minimum bid price rule and faces potential delisting if it does not achieve a closing bid of at least $1.00 per share for 10 consecutive business days by May 26, 2026.
Insights
MetaVia gets more time to fix its Nasdaq bid-price deficiency, but delisting risk remains.
MetaVia Inc. has secured a 180‑day extension from Nasdaq, moving its deadline to regain the $1.00 per share minimum bid price to
The company already has shareholder authorization, granted on
If MetaVia’s stock does not meet the minimum bid requirement by
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of Registrant as Specified in Its Charter)
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
(Address of principal executive offices) | (Zip Code) |
(
(Registrant’s telephone number, including area code)
Not applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
| Trading Symbol(s) |
| Name of each exchange on which registered |
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 3.01.Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
As previously reported, on May 29, 2025, MetaVia Inc. (the “Company”) received a letter (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) informing the Company that because the closing bid price for the Company’s common stock listed on Nasdaq was below $1.00 for 30 consecutive trading days, the Company is not in compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”).
In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company had a period of 180 calendar days from May 29, 2025, or until November 25, 2025, to regain compliance with the Minimum Bid Price Requirement.
On November 7, 2025, the Company submitted a request to Nasdaq for a 180-day extension to regain compliance with the Minimum Bid Price Requirement. The Company indicated to Nasdaq that it had demonstrated more than $5 million in stockholders’ equity as of September 30, 2025, and provided notice of its intention to cure the deficiency during the extended compliance period by effecting a reverse stock split, if necessary, and in sufficient time to evidence a closing bid price of at least $1.00 per share for a minimum of ten consecutive business days prior to the expiration of the extended compliance period. On June 30, 2025, the Company’s stockholders approved an amendment to the Company’s Third Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split of the Company’s issued and outstanding common stock at a ratio between 1-for-5 to 1-for-30, with the decision of whether to implement such reverse stock split being subject to the discretion of the Company’s Board of Directors.
On November 26, 2025, the Company received a letter from Nasdaq advising that the Company had been granted a 180-day extension to May 26, 2026 to regain compliance with the Minimum Bid Price Requirement, in accordance with Nasdaq Listing Rule 5810(c)(3)(A).
The Company intends to continue actively monitoring the closing bid price for the Company’s common stock between now and May 26, 2026, and will consider available options to resolve the deficiency, including effecting a reverse stock split as stated above, and regain compliance with the Minimum Bid Price Requirement.
If the Company does not regain compliance within the allotted compliance period, Nasdaq will provide notice that the Company’s common stock will be subject to delisting. The Company would then be entitled to appeal that determination to a Nasdaq hearings panel. There can be no assurance that the Company will regain compliance with the Minimum Bid Price Requirement during this 180-day extension period or maintain compliance with the other Nasdaq listing requirements.
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| METAVIA INC. | ||
Date: November 26, 2025 | By: | /s/ Hyung Heon Kim | |
Hyung Heon Kim | |||
President and Chief Executive Officer | |||
FAQ
Why did MetaVia Inc. (MTVA) receive a Nasdaq non-compliance notice?
What extension did MetaVia (MTVA) receive from Nasdaq to regain compliance?
How does MetaVia plan to regain Nasdaq minimum bid price compliance?
What financial threshold did MetaVia report in connection with the Nasdaq extension?
What happens if MetaVia does not regain compliance by May 26, 2026?
Has MetaVia’s reverse stock split already been carried out?
